NAFDAC Pharmacovigilance and Post-Marketing Surveillance (PV/PMS) Directorate Guidelines for Post Marketing Surveillance in Nigeria
Ministry of Industry, Trade and Investment, National Agency for Food and Drug Administration and Control, Nigeria
The purpose of this guideline is to strengthen the NAFDAC system for effective post-marketing surveillance of medicines, and regulated products including medical devices to ensure that only quality and safe medicines and other regulated products are distributed throughout the country. The implementation of This guideline will enable NAFDAC to generate scientific evidence on the quality and safety of medicines and medical devices for improved health outcomes.
You are viewing a previous version. Click here to view the current version.
Read in full screenProcess Flow
Department of Pharmacovigilance& Post Marketing Surveillance ⬤
Office of the Director General NAFDAC ⬤
Office of the Permanent Secretary, Ministry of Health ⬤
Office of the Minister of State for Health ⬤
Office of the minister for health ⬤
Federal Executive Council ⬤
NAFDAC Pharmacovigilance and Post-Marketing Surveillance (PV/PMS) Directorate Guidelines for Post Marketing Surveillance in Nigeria Current Version
January 2022
The purpose of this guideline is to strengthen the NAFDAC system for effective post-marketing surveillance of medicines, and regulated products including medical devices to ensure that only quality and safe medicines and other regulated products are distributed throughout the country. The implementation of This guideline will enable NAFDAC to generate scientific evidence on the quality and safety of medicines and medical devices for improved health outcomes.
Thank you for requesting an expert analysis
A member of our team will review your request and reply back to the email address on file.